Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|11|1643-1650

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.11, 2015-11, pp. : 1643-1650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 98-103

Karger

Access to resources Recommend Favorite

Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency Ablation

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 132-138

Karger

Access to resources Recommend Favorite

Can ACE Inhibitors and Angiotensin Receptor Blockers Be Detrimental in CKD Patients?

By  

Nephron Clin Pract, Vol. 118, Iss. 4, 2011-03 ,pp. : c407-c419

Karger

Access to resources Recommend Favorite

Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E62-E72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 29-41

John Wiley & Sons Inc

Access to resources Recommend Favorite